However, in mice harboring LLC-sh21 tumors, treatment with the anti–PD-1 antibody decreased primary tumor volume by more than 80%, a statistically significant difference compared with all the other experimental groups (Fig 4F). Here, PDCD1 is linked to neoplasm.